UniSuper Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.7M Buy
767,067
+47,397
+7% +$2.57M 0.17% 109
2026
Q1
$45.2M Sell
719,670
-41,014
-5% -$3.28M 0.3% 71
2025
Q4
$72.5M Sell
760,684
-318,658
-30% -$31.2M 0.43% 46
2025
Q3
$105M Buy
1,079,342
+169,181
+19% +$17.5M 0.65% 23
2025
Q2
$97.8M Sell
910,161
-67,930
-7% -$6.87M 0.66% 24
2025
Q1
$98.7M Buy
978,091
+2,130
+0.2% +$214K 0.74% 20
2024
Q4
$87.2M Buy
975,961
+550,439
+129% +$48.5M 0.63% 24
2024
Q3
$35.7M Buy
425,522
+355,303
+506% +$28M 0.27% 79
2024
Q2
$5.41M Buy
70,219
+36,487
+108% +$2.67M 0.04% 205
2024
Q1
$2.31M Buy
33,732
+21,623
+179% +$1.39M 0.02% 232
2023
Q4
$700K Sell
12,109
-9,855
-45% -$526K 0.01% 292
2023
Q3
$1.16M Sell
21,964
-2,308
-10% -$121K 0.01% 256
2023
Q2
$1.31M Buy
+24,272
New +$1.27M 0.01% 252

Other funds holding BSX

UniSuper Management's BSX Position: Q2 2026 in Review

UniSuper Management increased its Boston Scientific (BSX) stake by 6.6% in Q2 2026, buying an estimated $2.57M and bringing the position to 767,067 shares worth $32.7M. The position accounts for 0.17% of the portfolio, ranked #109.

UniSuper Management first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $105M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • UniSuper Management held 767,067 shares of Boston Scientific worth $32.7M as of Q2 2026.
  • UniSuper Management bought 47,397 Boston Scientific shares in Q2 2026, an estimated $2.57M.
  • Boston Scientific made up 0.17% of UniSuper Management's portfolio in Q2 2026, its #109 holding.
  • UniSuper Management first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
  • UniSuper Management's Boston Scientific position peaked at $105M in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.